The bill establishes a predictable approval and labeling pathway to let producers use certain feed/food-additive substances to reduce foodborne pathogens and inform buyers, but it increases compliance costs and regulatory uncertainty and may limit veterinary oversight with potential animal-health risks.
Farmers and other food-animal producers can use FDA-approved feed/food-additive substances to reduce foodborne pathogens in animals, which could lower contamination in the food supply and reduce foodborne illness risk.
Manufacturers (including small businesses) gain a clearer regulatory pathway and predictable data and labeling requirements for novel feed/food-additive products, making it easier to prepare petitions and plan product development.
Farmers and purchasers can see on product labels intended non-therapeutic effects on animal gastrointestinal structure/function, helping buyers make more informed choices about feed additives.
Manufacturers and producers face higher testing and documentation costs because petitions must include full investigation reports and efficacy data, increasing compliance costs particularly for small firms.
Farmers and animals could face health risks because classifying these substances as food additives rather than drugs may limit veterinary oversight for interventions that alter animal microbiomes, raising the potential for misuse or unforeseen animal-health consequences.
Manufacturers face uncertainty about which products qualify due to narrow exclusions (e.g., hormones, prior drugs) and agency rulemaking discretion, which could delay market entry and slow innovation.
Based on analysis of 2 sections of legislative text.
Creates a new FD&C Act pathway for zootechnical animal food substances, defines them, requires section 409 petitions and a required label, and clarifies they are not drugs solely for gut‑targeting effects.
Introduced March 18, 2025 by Nicholas A. Langworthy · Last progress March 18, 2025
Creates a new category of animal feed/water substances called “zootechnical animal food substances,” treats them as food additives under the Federal Food, Drug, and Cosmetic Act, and sets a specific regulatory and labeling pathway for bringing them into interstate commerce. The measure defines what those substances are and are not, requires petition data showing they will achieve their intended, non‑therapeutic effects in the gut, mandates a required caution label, and clarifies that the FDA may not require producers to use any such substance.